PRF Technologies (PRFX) Cash & Equivalents (2019 - 2025)

PRF Technologies (PRFX) posted quarterly Cash & Equivalents of $3.1 million for Q4 2025, down 26.66% year-on-year from $4.3 million in Q4 2024, and down 10.56% on a QoQ basis from $3.5 million in Q2 2025.

PRF Technologies (PRFX) Cash & Equivalents (2019 - 2025) Analysis & Trends

PRF Technologies (PRFX) has reported Cash & Equivalents for 7 consecutive years, with $3.1 million the latest figure, recorded in Q4 2025.

  • Quarterly Cash & Equivalents fell 26.66% year-over-year to $3.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.1 million (down 26.66% YoY) and the FY2025 annual result came in at $3.1 million, down 26.66% from the prior year.
  • Cash & Equivalents declined to $3.1 million in Q4 2025 per PRFX's latest filing, from $3.5 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for PRFX reached as high as $19.4 million in Q1 2021 and fell as low as $2.8 million in Q2 2024.
  • A 5-year average of $9.4 million and a median of $7.6 million in 2023 frame the typical range for Cash & Equivalents.
  • Annual changes were most pronounced in 2021 — Cash & Equivalents surged 3137.09% — and 2022, when it slumped 75.23%.
  • Year by year, Cash & Equivalents stood at $16.5 million in 2021, then sank by 75.23% to $4.1 million in 2022, then soared by 95.95% to $8.0 million in 2023, then tumbled by 46.91% to $4.3 million in 2024, then decreased by 26.66% to $3.1 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods registered $3.1 million, $3.5 million, and $4.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 1.76 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 3.74 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 3.79 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 1.28 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 33.59 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 266.50 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 428.00 Mn
10 PRF Technologies 745,168.93 451,168.93 - 3.13 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 3.13 Mn
Jun 30, 2025 3.49 Mn
Dec 31, 2024 4.26 Mn
Jun 30, 2024 2.79 Mn
Mar 31, 2024 4.33 Mn
Dec 31, 2023 8.03 Mn
Sep 30, 2023 7.56 Mn
Jun 30, 2023 5.15 Mn
Mar 31, 2023 8.15 Mn
Dec 31, 2022 4.10 Mn
Sep 30, 2022 6.95 Mn
Jun 30, 2022 13.87 Mn
Mar 31, 2022 16.57 Mn
Dec 31, 2021 16.54 Mn
Sep 30, 2021 18.34 Mn
Jun 30, 2021 17.80 Mn
Mar 31, 2021 19.44 Mn
Dec 31, 2020 15.68 Mn
Sep 30, 2020 17.72 Mn
Jun 30, 2020 550,000.00